Share:
Peer-Reviewed Publication
Med Oncol2026;43(9)July 17, 2026Journal Article

Formulation development and preliminary biological evaluation of a menthol modified thermoresponsive tamoxifen sol-gel.

Saleha Faheem1, Huma Hameed2, Sami A Al-Hussain3, Ali Irfan4, Shazia Akram Ghumman5, Magdi E A Zaki6
1Faculty of Pharmaceutical Sciences, University of Central Punjab, Lahore, 54000, Pakistan.
2Faculty of Pharmaceutical Sciences, University of Central Punjab, Lahore, 54000, Pakistan. huma.hameed@ucp.edu.pk.
3Department of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), 11623, Riyadh, Saudi Arabia.
4The Green Institute of Chemical Biomedical and Environmental Sciences (GICBES), Lahore, 54000, Pakistan.
5College of Pharmacy, University of Sargodha, Sargodha, 40100, Pakistan.
6Department of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), 11623, Riyadh, Saudi Arabia. mezaki@imamu.edu.sa.

Abstract

Localized drug delivery strategies offer potential advantages in improving therapeutic concentration at tumor sites while minimizing systemic exposure. In this study, a thermoresponsive poloxamer based sol-gel system incorporating tamoxifen citrate with L-menthol was developed and characterized for potential intratumoral application. The formulation was prepared using the cold method and optimized…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.